The Effect of 6-Weeks of Aerobic Exercise Training on Serum Fetuin-A levels in Non-Diabetic Obese Women

Abstract

Emerging evidence suggests that fetuin-A, a liver-derived glycoprotein, represents an important factor in the pathophysiology of the metabolic syndrome, type 2 diabetes and cardiovascular disease. So far circulating fetuin-A was found to be increased in fatty liver disease, however, the precise mechanisms regulating fetuin-A expression and secretion are largely unknown. Here we assessed serum fetuin-A levels in 14 non-diabetic, obese women (BMI 36.5±1.5 kg/m²) before and after a 6-week aerobic exercise program. Despite decreasing waist circumference (from 114.9±3.5 to 112.3±3.2 cm; P=0.006) and body fat content (from 44.1±1.5% to 43.4±1.5%; P=0.022) regular exercise 3-times per week over a 6-week period did not affect serum fetuin-A levels (before vs. after: 0.440±0.018 vs. 0.440±0.014 μg/ml; P=0.767). Thus, our data provide evidence against a major role of exercise in the regulation of serum fetuin-A levels in non-diabetic obese women.

Key words

fetuin-A - obesity - aerobic exercise

References

• 1 Das SK, Saltzman E, McCrory MA. et al . Energy expenditure is very high in extremely obese women.  J Nutr. 2004;  134 1412-1416
• 2 Devries MC, Samjoo IA, Hamadeh MJ. et al . Effect of endurance exercise on hepatic lipid content, enzymes, and adiposity in men and women.  Obesity. 2008;  16 2281-2288
• 3 Ellis KJ. Selected body composition methods can be used in field studies.  J Nutr. 2001;  131 1589S-1595S
• 4 Fiore CE, Celotta G, Politi GG. et al . Association of high alpha2-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass.  Atherosclerosis. 2007;  195 110-115
• 5 Goele K, Bosy-Westphal A, Rumcker B. et al . Influence of Changes in Body Composition and Adaptive Thermogenesis on the Difference between Measured and Predicted Weight Loss in Obese Women.  Obes Facts. 2009;  2 105-109
• 6 Ix JH, Wassel CL, Kanaya AM. et al . Fetuin-A and incident diabetes mellitus in older persons.  JAMA. 2008;  300 182-188
• 7 Matthews DR, Hosker JP, Rudenski AS. et al . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
• 8 Mori K, Emoto M, Araki T. et al . Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus.  Metabolism. 2008;  57 1248-1252
• 9 Mori K, Emoto M, Araki T. et al . Association of serum fetuin-A with carotid arterial stiffness.  Clin Endocrinol. 2007;  66 246-250
• 10 Mori K, Emoto M, Yokoyama H. et al . Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects.  Diabetes Care. 2006;  29 468
• 11 Reinehr T, Roth CL. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss.  J Clin Endocrinol Metab. 2008;  93 4479-4485
• 12 Stefan N, Fritsche A, Weikert C. et al . Plasma fetuin-A levels and the risk of type 2 diabetes.  Diabetes. 2008;  57 2762-2767
• 13 Stefan N, Hennige AM, Staiger H. et al . Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.  Diabetes Care. 2006;  29 853-857
• 14 Weikert C, Stefan N, Schulze MB. et al . Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.  Circulation. 2008;  118 2555-2562

Correspondence